ACAD : Insider Transactions for Acadia Pharmaceuticals Inc | J3SG

Sign in:	Email	Password save:

		Company Reports
Find Symbol

Recent: Companies Filers Institutions

Membership is free, please Sign Up.

My Recent Searches

Help

Roster

Institutions

Add To Portfolo/Alerts

Get Insiders for :

Acadia Pharmaceuticals Inc (ACAD)

$14.86

0.32 (2.11%) as of 4:30 Tue 5/14

Download

Exchange:

Nasdaq National Market

Security Type:

Common

Shares Out:

160,760,000

Market Cap:

2.39(B)

Last Volume:

2,930,837

Avg Vol:

1,645,649

52 Week Range:

$15.21 - $33.465

Level I Sector:

Health Care

Level II Sector:

Drugs

Level III Sector:

Biotechnology

Member Indexes:

	NASDAQ BIOTECHNOLOGY		NASDAQ COMPOSITE
	NASDAQ NNM COMPOSITE

Rankings:

Insider 3 Months : -

Insider 6 Months : -

Insider 3/6 Months : -

Guru Rank Number : -

Guru Rank Value : -

Guru Occurances : -


6 Months 1 Year 2 Year

Company Profile Acadia Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system disorders. Co. has a portfolio of product including its drug, NUPLAZID (pimavanserin), which has been approved by the U.S. Food and Drug Administration for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. NUPLAZID is a selective serotonin inverse agonist/antagonist, targeting 5-HT2A receptors with no appreciable affinity for dopaminergic, histaminergic, or muscarinic receptors.

D/I:

D is for direct shares.
I is for indirect shares.

D/I refers to the Direct or Indirect shares traded vs. held.

Forms:

A Form 4 is a form filed by an insider to indicate a change in ownership.

A Form 3 is a form filed by an insider to indicate an initial ownership of a security.

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.

Actions:

B	Buy
S	Sell
OE	Option Exercised
A	Acquired
D	Disposed
AB	Automatic Buy
AS	Automatic Sell
IO	Initial Ownership

Download:

Download only Transactions Forms. (Default)

Download only Summary Infomation.

Download both Transactions and Summary Data

Summary (Direct Transactions Only)	3 Months	6 Months	12 Months	24 Months
Total Shares Bought	0	0	896,522	896,522
Total Buy Value	$0	$0	$22,707,098	$22,707,098
Total People Bought	0	0	1	1
Total Buy Transactions	0	0	3	3
Total Shares Sold	89,116	108,222	403,356	457,753
Total Sell Value	$1,625,639	$2,106,506	$9,734,682	$10,734,640
Total People Sold	4	5	6	7
Total Sell Transactions	15	22	35	57
End Date	2024-02-15	2023-11-14	2023-05-16	2022-05-16

Adjust Filter Settings

Records found: 642

Page 20 of 26

Filer's Name

Relation Title

Off-Dir-10%

D/I

Rank

3m +/-

Form

Iversen Leslie L

– • –

2013-09-12

4

OE

$1.30

$99,600

D/D

60,000

73,500

-

Kaplan Lester J Ph D

– • –

2013-09-12

4

AS

$22.90

$1,519,672

D/D

(66,356)

8,500

-

Kaplan Lester J Ph D

– • –

2013-09-12

4

OE

$2.16

$289,823

D/D

66,356

74,856

-

– • –

2013-09-10

4

AS

$22.80

$1,052,145

D/D

(46,153)

0

-

– • –

2013-09-10

4

OE

$1.30

$59,999

D/D

46,153

46,153

-

Rasmussen Torsten

– • –

2013-09-03

4

AS

$20.28

$811,100

I/I

(40,000)

8,500

-

Rasmussen Torsten

– • –

2013-09-03

4

OE

$1.30

$60,600

I/I

40,000

48,500

-

– • –

2013-08-26

4

AS

$20.62

$310,211

D/D

(15,000)

0

-

– • –

2013-08-26

4

OE

$7.67

$123,250

D/D

15,000

15,000

-

CEO

• • –

2013-08-13

4

AS

$20.14

$1,063,061

I/I

(52,771)

109,049

-

CEO

• • –

2013-08-13

4

GA

$0.00

$0

I/I

52,771

161,820

-

CEO

• • –

2013-08-13

4

GD

$0.00

$0

D/D

52,771

0

-

CEO

• • –

2013-08-13

4

OE

$1.08

$56,993

D/D

52,771

52,771

-

EXEC VP, CFO AND CBO

• – –

2013-08-13

4

AS

$20.15

$1,209,180

I/I

(60,000)

0

-

EXEC VP, CFO AND CBO

• – –

2013-08-13

4

GA

$0.00

$0

I/I

60,000

60,000

-

EXEC VP, CFO AND CBO

• – –

2013-08-13

4

GD

$0.00

$0

D/D

60,000

31,585

-

EXEC VP, CFO AND CBO

• – –

2013-08-13

4

OE

$1.55

$69,750

D/D

45,000

91,585

-

Baker Brothers Life Sciences Lp

Director

– • •

2013-06-05

4

B

$14.46

$12,657,999

I/I

872,585

440,802

2.25

-

Baker Brothers Life Sciences Lp

Director

– • •

2013-06-04

4

B

$14.42

$10,110,693

I/I

699,776

421,826

2.25

-

Baker Brothers Life Sciences Lp

Director

– • •

2013-06-03

4

B

$14.00

$10,794,615

I/I

767,953

406,609

2.25

-

Baker Brothers Life Sciences Lp

Director

– • •

2013-05-15

4

B

$12.50

$24,912,500

I/I

1,993,000

389,909

2.25

-

CEO

• • –

2013-05-02

4

AS

$12.34

$252,396

I/I

(20,449)

109,049

-

CEO

• • –

2013-05-02

4

GA

$0.00

$0

I/I

20,449

129,498

-

CEO

• • –

2013-05-02

4

GD

$0.00

$0

D/D

20,449

0

-

CEO

• • –

2013-05-02

4

OE

$1.08

$22,085

D/D

20,449

20,449

-

642 Records found	Previous 20 21 22 23 24 25 26	Page 20 of 26

	Transaction Code Key:				Ownership Code Key
	B	- Buy	AB	- Automatic Buy	D	- Direct Ownership
	S	- Sell	AS	- Automatic Sell	I	- Indirect Ownership
	OE	- Options Exercised	A	- Acquired
	IO	- Initital Ownership	D	- Disposed

Copyright © 2024 j3sg.com | Disclaimer & Terms of use Products & Service About Us Contact Us

Summary:

Chart:

3m +/-:

This represents the company's 3 month price change. The initial price is based on the closing price of the stock on the day the transaction took place. Purchases & sales are viewed as long & short positions respectively.